SUBSCRIBE
SUBSCRIBE

Ventracor Limited Announces 200th VentraAssist LVAD (Left Ventricular Assist Device) Implant

February 11, 2008 | 
1 min read

Sydney, Feb 11, 2008 (ABN Newswire) - Ventracor (ASX: VCR)(US: VTCRY) has implanted the 200th patient with its VentrAssist(tm) Left Ventricular Assist Device (LVAD).

Australia
MORE ON THIS TOPIC
Genetown
The Best Way to Answer Salary Interview Questions
June 11, 2024
 · 
4 min read
 · 
Lorenzo Soliman
Drug Development
Kazia’s Star Asset Suffers Surprise Letdown in Global Glioblastoma Study
August 2, 2022
 · 
3 min read
 · 
Tristan Manalac
Drug Development
Sapience, Intensity, Kazia and Transcenta Tout Early Success at ASCO
June 3, 2022
 · 
3 min read
 · 
Vanessa Doctor, RN
Drug Development
Inaugural Patient Injected with Cancer-Killing Oncolytic Virus
May 24, 2022
 · 
2 min read
 · 
Jazmine Colatriano M.S.